Centene Corporation, with its focus on providing healthcare services to underinsured and uninsured segments, operates in a stable industry but faces challenges from regulatory changes and competitive pressures. The diverse product offerings across managed and specialty care make it resilient, although financial performance needs careful monitoring.
Centene's fundamental rating reflects a moderate assessment with room for improvement in key financial metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 4 |
The historical ratings show consistent scoring in key areas with a slight overall improvement.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| Current | 2 | 5 | 1 | 1 | 1 | 1 | 4 |
| 2026-06-22 | 2 | 5 | 1 | 1 | 1 | 1 | 4 |
Analysts remain optimistic with a notable upside potential, suggesting a median target well above current levels.
| High | Low | Median | Consensus |
|---|---|---|---|
| 80 | 39 | 60 | 59 |
The stock enjoys a positive sentiment with the majority of analysts recommending a buy.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 27 | |
| Hold | 15 | |
| Sell | 1 | |
| Strong Sell | 0 |
Centene Corporation, with its strong position in the healthcare sector, benefits from steady demand for its services. Its moderate valuation and diverse service offerings shield it from significant downturns, yet the low financial metrics may concern potential investors. Regulatory challenges and the competitive landscape remain hurdles that could impact future performance. Nonetheless, the positive analyst sentiment supports investment while highlighting the need for diligence regarding financial health and market competition. Overall, Centene Corporation offers an intriguing blend of risk and potential reward for investors.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.